PL84258B1 - - Google Patents

Download PDF

Info

Publication number
PL84258B1
PL84258B1 PL1970175151A PL17515170A PL84258B1 PL 84258 B1 PL84258 B1 PL 84258B1 PL 1970175151 A PL1970175151 A PL 1970175151A PL 17515170 A PL17515170 A PL 17515170A PL 84258 B1 PL84258 B1 PL 84258B1
Authority
PL
Poland
Prior art keywords
thieno
pyrimidine
carboxylic acid
morpholine
amino
Prior art date
Application number
PL1970175151A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL84258B1 publication Critical patent/PL84258B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL1970175151A 1969-08-08 1970-08-07 PL84258B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691940572 DE1940572A1 (de) 1969-08-08 1969-08-08 Neue 2-Aminoalkylamino-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
PL84258B1 true PL84258B1 (cg-RX-API-DMAC7.html) 1976-03-31

Family

ID=5742362

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1970142706A PL83617B1 (cg-RX-API-DMAC7.html) 1969-08-08 1970-08-07
PL1970175153A PL84246B1 (cg-RX-API-DMAC7.html) 1969-08-08 1970-08-07
PL1970175151A PL84258B1 (cg-RX-API-DMAC7.html) 1969-08-08 1970-08-07

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL1970142706A PL83617B1 (cg-RX-API-DMAC7.html) 1969-08-08 1970-08-07
PL1970175153A PL84246B1 (cg-RX-API-DMAC7.html) 1969-08-08 1970-08-07

Country Status (6)

Country Link
BG (1) BG17969A3 (cg-RX-API-DMAC7.html)
DE (1) DE1940572A1 (cg-RX-API-DMAC7.html)
PL (3) PL83617B1 (cg-RX-API-DMAC7.html)
RO (2) RO60647A (cg-RX-API-DMAC7.html)
SU (2) SU428607A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA705482B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003288994A1 (en) 2002-12-10 2004-06-30 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compounds and medicinal use thereof
AU2006237354B2 (en) * 2005-04-21 2012-03-01 Boehringer Ingelheim International Gmbh Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
DK2215092T3 (da) 2007-10-19 2012-05-07 Boehringer Ingelheim Int Substitueret piperidino-dihydrothienopyrimidin
CN101827853A (zh) 2007-10-19 2010-09-08 贝林格尔.英格海姆国际有限公司 杂环取代的哌嗪子基-二氢噻吩并嘧啶
US8486948B2 (en) 2007-10-19 2013-07-16 Boehringer Ingelheim International Gmbh Piperazinodihydrothienopyrimidine derivatives
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma

Also Published As

Publication number Publication date
PL83617B1 (cg-RX-API-DMAC7.html) 1975-12-31
PL84246B1 (cg-RX-API-DMAC7.html) 1976-03-31
SU428607A3 (cg-RX-API-DMAC7.html) 1974-05-15
ZA705482B (en) 1971-05-27
DE1940572A1 (de) 1971-02-11
BG17969A3 (cg-RX-API-DMAC7.html) 1974-03-05
RO60647A (cg-RX-API-DMAC7.html) 1976-08-15
SU419032A3 (ru) 1974-03-05
RO60600A (cg-RX-API-DMAC7.html) 1976-09-15

Similar Documents

Publication Publication Date Title
CA2263167C (en) Ether muscarinic antagonists
Jacobson et al. Functionalized congeners of 1, 3-dialkylxanthines: preparation of analogs with high affinity for adenosine receptors
SK180699A3 (en) HYDRAZINE DERIVATIVES, PREAPARATION PROCESS THEREOF, ITS USE ANDì (54) PHARMACEUTICAL COMPOSITION COMTAINING IT
PL147123B1 (en) Method of obtaining novel derivatives of dihydropyridazinone
Haroon et al. Alkyl 2-(2-(arylidene) alkylhydrazinyl) thiazole-4-carboxylates: Synthesis, acetyl cholinesterase inhibition and docking studies
Melloni et al. Synthesis and antiprotozoal activity of methylnitro derivatives of 2, 2'-biimidazole
PL84258B1 (cg-RX-API-DMAC7.html)
Lee et al. Mutagenicity of 22 N-nitrosamides and related compounds for Salmonella typhimurium TA1535
WO2003016248A2 (en) Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
Østby et al. Synthesis of 5‐substituted pyrrolo [1, 2‐b] pyridazines with antioxidant properties
Voegel et al. Synthesis and tautomeric equilibrium of 6-amino-5-benzyl-3-methylpyrazin-2-one. An acceptor-donor-donor nucleoside base analog
EP0447324A1 (fr) Dérivés de pyrimidinedione-2,4 et médicaments les contenant
FI65998B (fi) Foerfarande foer framstaellning av nya farmakologiskt aktiva pyrrolyl-pyridazinaminderivat
Braña et al. Benzimidazo [1, 2‐c] quinazoline dimers as potential antitumor agents
PT93673B (pt) Processo para a preparacao de derivados da piridina
JP5542931B2 (ja) Ｎ置換ピリジニウム化合物の調製のための方法及び物質
PL93755B1 (en) New pyrido%1,2a<-pyrimidine-derivatives[au6670474a]
Baker et al. PUROMYCIN. SYNTHETIC STUDIES. IV. GLUCOSYL DERIVATIVES OF 6-DIMETHYLAMINOPURINE
Hosmane et al. 5-Methyladenine: a transient intermediate in a translocative rearrangement
EP0366006B1 (en) Pyridylketoxime ether compound and pharmaceutical composition containing it
Schaeffer et al. Enzyme Inhibitors. VI. Studies on the Bulk Tolerance of Adenosine Deaminase for 6-Substituted Amino-9-(3-hydroxypropyl) purines1
Ferrarini et al. Synthesis of 1, 8-naphthyridine derivatives: Potential antihypertensive agents–Part VIII
Atwell et al. Potential antitumor agents. 22. Latentiated congeners of the 4'-(9-acridinylamino) methanesulfonanilides
Korytnyk et al. Guanylhydrazones with potential antileukemic activity. 2. Synthesis and structure-activity relationships of analogs of 4, 4'-diacetyl-N, N'-diphenylurea bis (guanylhydrazone)
KOHDA et al. Potentiation of the cytotoxicity of chloroethylnitrosourea by O6-arylmethylguanines